Company Search:
Advanced Search
Sponsored Links
Hubei Biocause Pharmaceutical Co., Ltd. Company Snapshot
Hubei Biocause Pharmaceutical Co., Ltd. operates in the Life insurance sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Biocause Pharmaceutical Co., Ltd. with three other insurance companies in Asia: China Life Insurance Company Limited of Taiwan (2017 sales of 268.23 billion Taiwanese Dollars [US$8.69 billion] ), Mercuries & Associates Investment Ltd of Taiwan (215.56 billion Taiwanese Dollars [US$6.98 billion] ), and Korean Reinsurance Company which is based in South Korea (9.01 trillion Korean Won [US$7.96 billion] ).

Sales Analysis. Sales increased substantially in 2017: Hubei Biocause Pharmaceutical Co., Ltd. reported sales of 53.41 billion Chinese Renmimbi (US$7.68 billion) for the year ending December of 2017. This represents an increase of 214.3% versus 2016, when the company's sales were 16.99 billion Chinese Renmimbi. Sales of Insurance saw an increase of 408.4% in 2017, from 9.23 billion Chinese Renmimbi to 46.91 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hubei Biocause Pharmaceutical Co., Ltd.
  Stock Performance Chart for Hubei Biocause Pharmaceutical Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 6.12
(Figures in Chinese Renmimbi)
1 Week 1.2%   13 Weeks 10.5%  
4 Weeks -5.7%   52 Weeks -39.6%  
Hubei Biocause Pharmaceutical Co., Ltd. Key Data:
  Ticker: 000627 Country: China
  Exchanges: SZN Major Industry: Insurance
    Sub Industry: Life Insurance
  2017 Sales 53,407,662,058
(Year Ending Jan 2018).
Employees: 5,099
  Currency: Chinese Renmimbi Market Cap: 30,236,650,490
  Fiscal Yr Ends: December Shares Outstanding: 4,940,629,165
  Share Type: A Gu Closely Held Shares: 3,277,015,260
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.